8d
Zacks.com on MSNHere's Why You Should Retain AMED Stock in Your Portfolio NowAmedisys' high Quality of Patient Care and Patient Satisfaction star ratings bring optimism to investors. Yet, a dull macroeconomic condition adds to the worry.
However, the cost per day in this segment increased by 3.5% year-over-year. Contessa, another segment of Amedisys, reported sluggish revenue at $8.1 million in the fourth quarter of 2024, which was a ...
However, the cost per day in this segment increased by 3.5% year-over-year. Contessa, another segment of Amedisys, reported sluggish revenue at $8.1 million in the fourth quarter of 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results